Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	vacuole	DPP4 AP2M1 RAB24 DRAM1 PIGR MYO6 TRIM32 MTOR ACLY DEPDC5 ABCD1 ADA DYNC1H1 TECPR1	1.33e-05	913	83	14	GO:0005773
GeneOntologyCellularComponent	ciliary tip	IFT140 DYNC2LI1 IFT172 KIF7	3.94e-05	48	83	4	GO:0097542
GeneOntologyCellularComponent	membrane coat	ARL6 AP2M1 NECAP2 SLC18A3 KLHL12	6.47e-05	106	83	5	GO:0030117
GeneOntologyCellularComponent	coated membrane	ARL6 AP2M1 NECAP2 SLC18A3 KLHL12	6.47e-05	106	83	5	GO:0048475
GeneOntologyCellularComponent	lysosome	DPP4 AP2M1 DRAM1 PIGR MYO6 MTOR ACLY DEPDC5 ABCD1 ADA DYNC1H1 TECPR1	8.26e-05	811	83	12	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	DPP4 AP2M1 DRAM1 PIGR MYO6 MTOR ACLY DEPDC5 ABCD1 ADA DYNC1H1 TECPR1	8.26e-05	811	83	12	GO:0000323
GeneOntologyCellularComponent	lysosomal membrane	DPP4 AP2M1 DRAM1 PIGR MYO6 MTOR DEPDC5 ABCD1 TECPR1	8.99e-05	462	83	9	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	DPP4 AP2M1 DRAM1 PIGR MYO6 MTOR DEPDC5 ABCD1 TECPR1	8.99e-05	462	83	9	GO:0098852
GeneOntologyCellularComponent	vesicle coat	AP2M1 NECAP2 SLC18A3 KLHL12	1.46e-04	67	83	4	GO:0030120
GeneOntologyCellularComponent	vacuolar membrane	DPP4 AP2M1 DRAM1 PIGR MYO6 MTOR DEPDC5 ABCD1 TECPR1	1.81e-04	507	83	9	GO:0005774
GeneOntologyCellularComponent	coated vesicle membrane	AP2M1 NECAP2 MYO6 SLC18A3 GRIA1 KLHL12	2.16e-04	215	83	6	GO:0030662
GeneOntologyCellularComponent	stereocilium membrane	MYO1C ADGRV1	2.31e-04	6	83	2	GO:0060171
GeneOntologyCellularComponent	clathrin-coated pit	AP2M1 NECAP2 MYO6 SLC18A3	2.90e-04	80	83	4	GO:0005905
GeneOntologyCellularComponent	neuronal cell body	DPP6 YKT6 MYO6 MTOR SIPA1L1 GLUL GRIA1 ITGA4 ADA DYNC1H1 PMM2	4.52e-04	835	83	11	GO:0043025
GeneOntologyCellularComponent	clathrin vesicle coat	AP2M1 NECAP2 SLC18A3	4.61e-04	38	83	3	GO:0030125
GeneOntologyCellularComponent	bBAF complex	SMARCA2 SMARCA4	6.87e-04	10	83	2	GO:0140092
GeneOntologyCellularComponent	unconventional myosin complex	MYO1C MYO6	8.37e-04	11	83	2	GO:0016461
GeneOntologyCellularComponent	endocytic vesicle	DPP4 AP2M1 MYO1C MYO6 MTOR SLC18A3 GRIA1	8.37e-04	384	83	7	GO:0030139
GeneOntologyCellularComponent	somatodendritic compartment	DPP6 YKT6 MYO6 MTOR SIPA1L1 GLUL GRIA1 ITGA4 ADA PREX1 DYNC1H1 LGI1 PMM2	1.06e-03	1228	83	13	GO:0036477
GeneOntologyCellularComponent	cell body	DPP6 YKT6 MYO6 MTOR SIPA1L1 GLUL GRIA1 ITGA4 ADA DYNC1H1 PMM2	1.09e-03	929	83	11	GO:0044297
GeneOntologyCellularComponent	dynein complex	DYNC2LI1 DYNC1H1 DNAH14	1.29e-03	54	83	3	GO:0030286
GeneOntologyCellularComponent	autophagosome	RAB24 MYO6 TRIM32 TECPR1	1.30e-03	119	83	4	GO:0005776
GeneOntologyCellularComponent	AP-2 adaptor complex	AP2M1 SLC18A3	1.37e-03	14	83	2	GO:0030122
GeneOntologyCellularComponent	npBAF complex	SMARCA2 SMARCA4	1.37e-03	14	83	2	GO:0071564
GeneOntologyCellularComponent	GBAF complex	SMARCA2 SMARCA4	1.37e-03	14	83	2	GO:0140288
GeneOntologyCellularComponent	clathrin coat	AP2M1 NECAP2 SLC18A3	1.44e-03	56	83	3	GO:0030118
GeneOntologyCellularComponent	leading edge membrane	DPP4 MYO1C MYO6 GRIA1 ADGRV1	1.50e-03	210	83	5	GO:0031256
GeneOntologyCellularComponent	clathrin coat of endocytic vesicle	AP2M1 SLC18A3	1.58e-03	15	83	2	GO:0030128
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	ARL6 IFT140 DYNC2LI1 IFT172 ADA DYNC1H1	1.65e-03	317	83	6	GO:0032838
GeneOntologyCellularComponent	nuclear envelope	DPY19L3 TMEM53 NUP155 MYO6 MTOR TNKS2 DYNC1H1 MYORG	1.71e-03	560	83	8	GO:0005635
GeneOntologyCellularComponent	nBAF complex	SMARCA2 SMARCA4	1.80e-03	16	83	2	GO:0071565
GeneOntologyCellularComponent	presynaptic endocytic zone	AP2M1 MYO6	2.29e-03	18	83	2	GO:0098833
GeneOntologyCellularComponent	clathrin-coated vesicle membrane	AP2M1 NECAP2 MYO6 SLC18A3	2.81e-03	147	83	4	GO:0030665
GeneOntologyCellularComponent	coated vesicle	AP2M1 NECAP2 MYO6 SLC18A3 GRIA1 KLHL12	3.10e-03	360	83	6	GO:0030135
GeneOntologyCellularComponent	cytoplasmic region	ARL6 IFT140 DYNC2LI1 IFT172 ADA DYNC1H1	3.10e-03	360	83	6	GO:0099568
GeneOntologyCellularComponent	clathrin coat of coated pit	AP2M1 SLC18A3	3.11e-03	21	83	2	GO:0030132
GeneOntologyCellularComponent	microtubule associated complex	DYNC2LI1 DYNC1H1 DNAH14 KIF7	3.89e-03	161	83	4	GO:0005875
GeneOntologyCellularComponent	microbody	TKT ABCD3 ABCD1 ACOX2	3.97e-03	162	83	4	GO:0042579
GeneOntologyCellularComponent	peroxisome	TKT ABCD3 ABCD1 ACOX2	3.97e-03	162	83	4	GO:0005777
GeneOntologyCellularComponent	cytoplasmic dynein complex	DYNC2LI1 DYNC1H1	4.06e-03	24	83	2	GO:0005868
GeneOntologyCellularComponent	ciliary transition zone	IFT140 DYNC2LI1 ADGRV1	4.12e-03	81	83	3	GO:0035869
GeneOntologyCellularComponent	neuron projection membrane	MYO1C GRIA1 ADGRV1	4.27e-03	82	83	3	GO:0032589
GeneOntologyCellularComponent	glutamatergic synapse	AP2M1 NRXN3 MYO6 MTOR SIPA1L1 GRIA1 IL1RAP LGI1 EFR3A	5.06e-03	817	83	9	GO:0098978
GeneOntologyCellularComponent	microtubule	ARL6 EML5 DYNC2LI1 EML6 DYNC1H1 DNAH14 KIF7	5.27e-03	533	83	7	GO:0005874
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	AP2M1 NECAP2 YKT6 RAB24 YIPF1 MYO1C PIGR MYO6 SLC18A3 GRIA1 KLHL12 VPS29	5.33e-03	1307	83	12	GO:0030659
GeneOntologyCellularComponent	intraciliary transport particle	IFT140 IFT172	5.51e-03	28	83	2	GO:0030990
GeneOntologyCellularComponent	vesicle membrane	AP2M1 NECAP2 YKT6 RAB24 YIPF1 MYO1C PIGR MYO6 SLC18A3 GRIA1 KLHL12 VPS29	5.93e-03	1325	83	12	GO:0012506
GeneOntologyCellularComponent	SWI/SNF complex	SMARCA2 SMARCA4	6.30e-03	30	83	2	GO:0016514
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	MYO1C SMARCA2 SMARCA4	6.61e-03	96	83	3	GO:0070603
GeneOntologyCellularComponent	clathrin adaptor complex	AP2M1 SLC18A3	6.72e-03	31	83	2	GO:0030131
HumanPheno	Abnormality of the sense of smell	ARL6 PROKR2 TRIM32 IFT172 ARNT2 KIF7 LGI1	2.80e-05	127	37	7	HP:0004408
HumanPheno	Hydrometrocolpos	ARL6 TRIM32 DYNC2LI1 IFT172	4.92e-05	29	37	4	HP:0030010
HumanPheno	Micromelia	IFT140 DYNC2LI1 IFT172 MATN3 GLUL KIF7	4.93e-05	94	37	6	HP:0002983
HumanPheno	Abnormal fifth toe morphology	ARL6 IFT140 DYNC2LI1 IFT172 SMARCA4 KIF7	4.93e-05	94	37	6	HP:0010322
HumanPheno	Enlarged joints	MATN3 SMARCA2 KIF7	9.60e-05	13	37	3	HP:0003037
HumanPheno	Macrostomia	IFT140 AP2M1 MTOR TMEM70 SMARCA2 SMARCA4 KIF7 PMM2	1.39e-04	220	37	8	HP:0000181
HumanPheno	Wide mouth	IFT140 AP2M1 MTOR TMEM70 SMARCA2 SMARCA4 KIF7 PMM2	1.39e-04	220	37	8	HP:0000154
HumanPheno	Postaxial foot polydactyly	ARL6 IFT140 DYNC2LI1 IFT172 KIF7	1.50e-04	72	37	5	HP:0001830
HumanPheno	Focal cortical dysplasia	MTOR DEPDC5 DYNC1H1	1.51e-04	15	37	3	HP:0032046
HumanPheno	Long philtrum	ARL6 AP2M1 TMEM53 TRIM32 MTOR IFT172 TMEM70 SMARCA2 SMARCA4 KIF7 PMM2	1.51e-04	429	37	11	HP:0000343
HumanPheno	Autistic behavior	ARL6 IFT140 AP2M1 PROKR2 TRIM32 MTOR IFT172 KAT8 ARNT2 SMARCA2 SMARCA4 GRIA1 DEPDC5 ADGRV1	1.52e-04	678	37	14	HP:0000729
HumanPheno	Microdontia	ARL6 IFT140 TRIM32 DYNC2LI1 IFT172 SMARCA2 ADGRV1	2.15e-04	175	37	7	HP:0000691
HumanPheno	Depressed nasal bridge	ARL6 IFT140 PROKR2 TRIM32 DYNC2LI1 MTOR SLC18A3 IFT172 KAT8 GLUL SMARCA4 KIF7 PMM2	2.18e-04	612	37	13	HP:0005280
HumanPheno	Flattened nasal bridge	ARL6 IFT140 PROKR2 TRIM32 DYNC2LI1 MTOR SLC18A3 IFT172 KAT8 GLUL SMARCA4 KIF7 PMM2	2.18e-04	612	37	13	HP:0000425
Domain	SnAC	SMARCA2 SMARCA4	1.90e-05	2	82	2	SM01314
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	1.90e-05	2	82	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	1.90e-05	2	82	2	IPR029295
Domain	SnAC	SMARCA2 SMARCA4	1.90e-05	2	82	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	1.90e-05	2	82	2	SM00951
Domain	FA_transporter	ABCD3 ABCD1	1.90e-05	2	82	2	IPR005283
Domain	QLQ	SMARCA2 SMARCA4	1.90e-05	2	82	2	PS51666
Domain	QLQ	SMARCA2 SMARCA4	1.90e-05	2	82	2	PF08880
Domain	P-loop_NTPase	ARL6 RAB24 MYO1C MYO6 DYNC2LI1 ABCD3 SMARCA2 NDST4 SMARCA4 ABCD1 DYNC1H1 DNAH14 KIF7	7.77e-05	848	82	13	IPR027417
Domain	HSA	SMARCA2 SMARCA4	1.14e-04	4	82	2	SM00573
Domain	ABC_membrane_2	ABCD3 ABCD1	1.14e-04	4	82	2	PF06472
Domain	HSA	SMARCA2 SMARCA4	1.14e-04	4	82	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	1.14e-04	4	82	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	1.14e-04	4	82	2	PF07529
Domain	BRK	SMARCA2 SMARCA4	2.82e-04	6	82	2	SM00592
Domain	-	DPP4 DPP6	2.82e-04	6	82	2	2.140.10.30
Domain	DPPIV_N	DPP4 DPP6	2.82e-04	6	82	2	PF00930
Domain	EPTP	ADGRV1 LGI1	2.82e-04	6	82	2	PF03736
Domain	IL-1_rcpt_I/II-typ	IL1R1 IL1RAP	2.82e-04	6	82	2	IPR004074
Domain	EPTP	ADGRV1 LGI1	2.82e-04	6	82	2	IPR005492
Domain	BRK_domain	SMARCA2 SMARCA4	2.82e-04	6	82	2	IPR006576
Domain	HELP	EML5 EML6	2.82e-04	6	82	2	PF03451
Domain	HELP	EML5 EML6	2.82e-04	6	82	2	IPR005108
Domain	WxxW_domain	MUC5B MUC2	2.82e-04	6	82	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC2	2.82e-04	6	82	2	PF13330
Domain	BRK	SMARCA2 SMARCA4	2.82e-04	6	82	2	PF07533
Domain	Peptidase_S9B_N	DPP4 DPP6	2.82e-04	6	82	2	IPR002469
Domain	EAR	ADGRV1 LGI1	3.94e-04	7	82	2	IPR009039
Domain	EAR	ADGRV1 LGI1	3.94e-04	7	82	2	PS50912
Domain	IL-1_rcpt_fam	IL1R1 IL1RAP	1.02e-03	11	82	2	IPR015621
Domain	Peptidase_S9	DPP4 DPP6	1.02e-03	11	82	2	PF00326
Domain	Peptidase_S9	DPP4 DPP6	1.02e-03	11	82	2	IPR001375
Domain	TIL	MUC5B MUC2	1.22e-03	12	82	2	PF01826
Domain	C8	MUC5B MUC2	1.22e-03	12	82	2	PF08742
Domain	Unchr_dom_Cys-rich	MUC5B MUC2	1.44e-03	13	82	2	IPR014853
Domain	C8	MUC5B MUC2	1.44e-03	13	82	2	SM00832
Domain	-	ARL6 RAB24 DYNC2LI1 ABCD3 SMARCA2 NDST4 SMARCA4 ABCD1 DYNC1H1 DNAH14	1.55e-03	746	82	10	3.40.50.300
Domain	Dynein_heavy_chain_D4_dom	DYNC1H1 DNAH14	1.67e-03	14	82	2	IPR024317
Domain	Dynein_HC_stalk	DYNC1H1 DNAH14	1.67e-03	14	82	2	IPR024743
Domain	MT	DYNC1H1 DNAH14	1.67e-03	14	82	2	PF12777
Domain	AAA_8	DYNC1H1 DNAH14	1.67e-03	14	82	2	PF12780
Domain	TIL_dom	MUC5B MUC2	1.67e-03	14	82	2	IPR002919
Domain	DHC_fam	DYNC1H1 DNAH14	1.93e-03	15	82	2	IPR026983
Domain	Dynein_heavy_dom	DYNC1H1 DNAH14	1.93e-03	15	82	2	IPR004273
Domain	Dynein_heavy	DYNC1H1 DNAH14	1.93e-03	15	82	2	PF03028
Domain	VWD	MUC5B MUC2	2.20e-03	16	82	2	SM00216
Domain	VWF_type-D	MUC5B MUC2	2.20e-03	16	82	2	IPR001846
Domain	VWFD	MUC5B MUC2	2.20e-03	16	82	2	PS51233
Domain	VWD	MUC5B MUC2	2.20e-03	16	82	2	PF00094
Domain	CTCK_1	MUC5B MUC2	2.78e-03	18	82	2	PS01185
Domain	VWC_out	MUC5B MUC2	3.10e-03	19	82	2	SM00215
Domain	Apc4_WD40_dom	EML5 EML6	3.44e-03	20	82	2	IPR024977
Domain	ANAPC4_WD40	EML5 EML6	3.44e-03	20	82	2	PF12894
Domain	TIR	IL1R1 IL1RAP	3.79e-03	21	82	2	SM00255
Domain	DEP	DEPDC5 PREX1	4.15e-03	22	82	2	PF00610
Domain	DEP	DEPDC5 PREX1	4.15e-03	22	82	2	PS50186
Domain	TIR	IL1R1 IL1RAP	4.15e-03	22	82	2	PF01582
Domain	DEP	DEPDC5 PREX1	4.15e-03	22	82	2	SM00049
Domain	CT	MUC5B MUC2	4.15e-03	22	82	2	SM00041
Pathway	WP_BARDETBIEDL_SYNDROME	ARL6 IFT140 TRIM32 DYNC2LI1 IFT172 KIF7	3.66e-06	88	67	6	M45557
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	AP2M1 YKT6 NUP155 MYO1C MYO6 TRIM32 ACLY ESYT1 LTN1 NELFB ABCD3 DYNC1H1	9.27e-09	560	83	12	35241646
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	AP2M1 NUP155 TRIM32 MTOR TKT ACLY IFT172 ESYT1 LTN1 GLUL ABCD3 VPS29 MYORG KIF7	7.32e-08	974	83	14	28675297
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ARL6 DPP4 CRYL1 AP2M1 EML5 MYO1C PIGR MYO6 TKT ACLY GLUL SLC5A9 ADGRV1 DYNC1H1	1.23e-07	1016	83	14	19056867
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	YKT6 NUP155 MTOR ACLY IFT172 ESYT1 NELFB ABCD3 SMARCA4 TRMT1L DYNC1H1	3.55e-07	638	83	11	33239621
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	NUP155 MYO1C MYO6 ACLY ESYT1 SIPA1L1 NELFB SMARCA4 DYNC1H1	4.89e-07	399	83	9	37536630
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	MYO1C MYO6 TRIM32 TKT GLUL ABCD3 DYNC1H1	3.41e-06	264	83	7	32814769
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AP2M1 NUP155 MYO1C MYO6 TRIM32 TKT ACLY ESYT1 LTN1 ABCD3 SMARCA2 SMARCA4 DYNC1H1 PMM2	3.65e-06	1353	83	14	29467282
Pubmed	Defining the membrane proteome of NK cells.	DPP4 NUP155 MYO1C MYO6 MTOR ACLY ESYT1 ABCD3 SMARCA4 ABCD1 ITGA4 IL1RAP DYNC1H1	3.87e-06	1168	83	13	19946888
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	5.63e-06	2	83	2	8670841
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23163725
Pubmed	Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.	DPP4 ADA	5.63e-06	2	83	2	24257613
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23076393
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	5.63e-06	2	83	2	15576411
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	5.63e-06	2	83	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	5.63e-06	2	83	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	5.63e-06	2	83	2	33027072
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23872584
Pubmed	Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo.	ABCD3 ABCD1	5.63e-06	2	83	2	15276650
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23088494
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	5.63e-06	2	83	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	5.63e-06	2	83	2	34812766
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	5.63e-06	2	83	2	30478150
Pubmed	Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty.	DPP4 ADA	5.63e-06	2	83	2	22062893
Pubmed	Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex.	IL1R1 IL1RAP	5.63e-06	2	83	2	7775431
Pubmed	Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism.	ABCD3 ABCD1	5.63e-06	2	83	2	9126326
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	5.63e-06	2	83	2	25808524
Pubmed	Direct association of adenosine deaminase with a T cell activation antigen, CD26.	DPP4 ADA	5.63e-06	2	83	2	8101391
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	5.63e-06	2	83	2	19144648
Pubmed	Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.	DPP4 ADA	5.63e-06	2	83	2	7594462
Pubmed	The Activity of Adenosine Deaminase and Dipeptidyl Peptidase IV in Children With Attention Deficit Hyperactivity Disorder.	DPP4 ADA	5.63e-06	2	83	2	37695015
Pubmed	Chromatin remodeler BRM is a key mediator of leucine-stimulated mTOR gene transcription in mouse mammary epithelial cells.	MTOR SMARCA2	5.63e-06	2	83	2	36587526
Pubmed	Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity.	DPP4 ADA	5.63e-06	2	83	2	30896318
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	5.63e-06	2	83	2	29391527
Pubmed	Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.	ABCD3 ABCD1	5.63e-06	2	83	2	9425230
Pubmed	Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26.	DPP4 ADA	5.63e-06	2	83	2	16670267
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	5.63e-06	2	83	2	37634210
Pubmed	Adrenoleukodystrophy: subcellular localization and degradation of adrenoleukodystrophy protein (ALDP/ABCD1) with naturally occurring missense mutations.	ABCD3 ABCD1	5.63e-06	2	83	2	17542813
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	5.63e-06	2	83	2	8208605
Pubmed	Secretory IgA is Concentrated in the Outer Layer of Colonic Mucus along with Gut Bacteria.	PIGR MUC2	5.63e-06	2	83	2	25437806
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	5.63e-06	2	83	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	5.63e-06	2	83	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	5.63e-06	2	83	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	5.63e-06	2	83	2	29848589
Pubmed	IL-1 receptor deficiency slows progression to diabetes in the NOD mouse.	IL1R1 IL1RAP	5.63e-06	2	83	2	14693705
Pubmed	Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.	DPP4 ADA	5.63e-06	2	83	2	21856036
Pubmed	Citrullination of adenosine deaminase impairs its binding to dipeptidyl peptidase IV.	DPP4 ADA	5.63e-06	2	83	2	35468399
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	5.63e-06	2	83	2	9603422
Pubmed	Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.	DPP4 ADA	5.63e-06	2	83	2	11772392
Pubmed	Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters.	ABCD3 ABCD1	5.63e-06	2	83	2	11248239
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	5.63e-06	2	83	2	27097303
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	5.63e-06	2	83	2	28038711
Pubmed	DEPDC5-dependent mTORC1 signaling mechanisms are critical for the anti-seizure effects of acute fasting.	MTOR DEPDC5	5.63e-06	2	83	2	36044864
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	5.63e-06	2	83	2	23963727
Pubmed	DEPDC5 mutations in familial and sporadic focal epilepsy.	MTOR DEPDC5	5.63e-06	2	83	2	28170089
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	5.63e-06	2	83	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	5.63e-06	2	83	2	31375262
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	5.63e-06	2	83	2	17075831
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	5.63e-06	2	83	2	32855269
Pubmed	Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.	DPP4 ADA	5.63e-06	2	83	2	11901152
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	5.63e-06	2	83	2	22721696
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	5.63e-06	2	83	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	5.63e-06	2	83	2	11719516
Pubmed	Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult.	DPP4 ADA	5.63e-06	2	83	2	25527815
Pubmed	CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.	DPP4 ITGA4	5.63e-06	2	83	2	26142332
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	5.63e-06	2	83	2	28706277
Pubmed	A Cross Talk Between BRG1 and Males Absent on the First Contributes to Reactive Oxygen Species Production in a Mouse Model of Nonalcoholic Steatohepatitis.	KAT8 SMARCA4	5.63e-06	2	83	2	29963902
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	5.63e-06	2	83	2	21092585
Pubmed	Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.	MTOR DEPDC5	5.63e-06	2	83	2	24585383
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	5.63e-06	2	83	2	26551623
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	5.63e-06	2	83	2	19458193
Pubmed	[Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells].	MUC5B MUC2	5.63e-06	2	83	2	20873538
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	5.63e-06	2	83	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	5.63e-06	2	83	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	5.63e-06	2	83	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	5.63e-06	2	83	2	26356327
Pubmed	Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.	DPP4 ADA	5.63e-06	2	83	2	21198750
Pubmed	3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis.	DPP4 ADA	5.63e-06	2	83	2	14684150
Pubmed	Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.	IL1R1 IL1RAP	5.63e-06	2	83	2	22778412
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	5.63e-06	2	83	2	12566296
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	5.63e-06	2	83	2	31406271
Pubmed	Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.	SMARCA2 SMARCA4	5.63e-06	2	83	2	29273066
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	AP2M1 MYO6 MTOR LTN1 NELFB ABCD3 SMARCA2 SMARCA4 DYNC1H1 PMM2	6.98e-06	704	83	10	29955894
Pubmed	Brg1-dependent chromatin remodelling is not essentially required during oligodendroglial differentiation.	GLUL SMARCA2 SMARCA4	7.18e-06	16	83	3	25568100
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	AP2M1 NUP155 MYO1C MYO6 TKT ACLY ESYT1 SIPA1L1 ABCD3 SMARCA4 TRMT1L ITGA4 DYNC1H1	8.52e-06	1257	83	13	36526897
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	AP2M1 NUP155 MYO1C MYO6 TRIM32 ACLY ESYT1 TMEM70 GLUL ABCD3 SMARCA4 GMDS DYNC1H1	8.52e-06	1257	83	13	37317656
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	PDE6A NUP155 PIGR MTOR ABCD3 SMARCA2 SMARCA4	8.56e-06	304	83	7	32235678
Pubmed	Ablation of BAF170 in Developing and Postnatal Dentate Gyrus Affects Neural Stem Cell Proliferation, Differentiation, and Learning.	GLUL SMARCA2 SMARCA4	1.04e-05	18	83	3	27392482
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CRYL1 AP2M1 MYO6 TRIM32 IFT172 SIPA1L1 GLUL SMARCA4 TNKS2 CABIN1 PREX1 DYNC1H1 LGI1	1.08e-05	1285	83	13	35914814
Pubmed	Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.	MYO1C MYO6 ACLY	1.24e-05	19	83	3	32888949
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ARL6 NECAP2 YKT6 NUP155 MYO1C MYO6 ESYT1 NELFB ABCD3 DYNC1H1	1.64e-05	777	83	10	35844135
Pubmed	DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1.	SMARCA2 SMARCA4	1.69e-05	3	83	2	30287812
Pubmed	Dipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome.	DPP4 ADA	1.69e-05	3	83	2	30394149
Pubmed	Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.	ABCD3 ABCD1	1.69e-05	3	83	2	10551832
Pubmed	Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.	IL1R1 IL1RAP	1.69e-05	3	83	2	9371760
Pubmed	Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness.	IL1R1 IL1RAP	1.69e-05	3	83	2	8706893
Pubmed	Gene regulation by IL-1beta independent of IL-1R1 in the mouse brain.	IL1R1 IL1RAP	1.69e-05	3	83	2	16358337
Pubmed	Peroxisomal ABC Transporters: An Update.	ABCD3 ABCD1	1.69e-05	3	83	2	34198763
Pubmed	BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.	SMARCA2 SMARCA4	1.69e-05	3	83	2	15034933
Pubmed	Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.	DPP4 ADA	1.69e-05	3	83	2	16059892
Interaction	C9orf78 interactions	AP2M1 YKT6 NUP155 MYO1C MYO6 TRIM32 ACLY ESYT1 LTN1 NELFB ABCD3 DYNC1H1	7.50e-06	620	82	12	int:C9orf78
Cytoband	13q33.1	METTL21C CCDC168	2.11e-04	12	83	2	13q33.1
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	ARL6 TRIM32 IFT172	2.88e-05	21	52	3	980
GeneFamily	ATP binding cassette subfamily D	ABCD3 ABCD1	4.85e-05	4	52	2	808
GeneFamily	CD molecules\|DASH family	DPP4 DPP6	1.69e-04	7	52	2	1205
GeneFamily	Dyneins, cytoplasmic	DYNC2LI1 DYNC1H1	6.20e-04	13	52	2	538
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1R1 IL1RAP	8.32e-04	15	52	2	1296
GeneFamily	CD molecules\|Mucins	MUC5B MUC2	1.65e-03	21	52	2	648
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT140 IFT172	2.15e-03	24	52	2	615
GeneFamily	Sulfotransferases, membrane bound	CHST10 NDST4	5.07e-03	37	52	2	763
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1R1 IL1RAP	6.49e-03	42	52	2	602
GeneFamily	WD repeat domain containing	IFT140 EML5 IFT172 EML6	6.77e-03	262	52	4	362
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 CDS1 NRXN3 EML5 DRAM1 PIGR ABCD3	5.45e-08	184	83	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 CDS1 NRXN3 DRAM1 PIGR ABCD3 ADGRV1	5.87e-08	186	83	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Club-club-11\|World / Class top	DPP4 PDE6A PIGR METTL21C MUC5B	6.12e-08	55	83	5	d1d832e1c98a89e2b461127922c3e4d7f42d7401
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDS1 DPY19L3 METTL21C CCDC168 IL1RAP DNAH14	9.05e-07	174	83	6	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR ABCD3 ADGRV1	1.42e-06	188	83	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP4 CRYL1 PIGR SLC5A9 LCT ADA	1.92e-06	198	83	6	6e6af8fad09f8e48b3f2ce463d5773b6a69864d1
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ELAPOR2 CDS1 NRXN3 PIGR ABCD3 ADGRV1	2.03e-06	200	83	6	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DPY19L3 PIGR GMDS MUC5B ADGRV1 PMM2	2.03e-06	200	83	6	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDS1 METTL21C CCDC168 IL1RAP DNAH14	1.96e-05	176	83	5	40993c41c1017b53039a337174fc56632b278609
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR ADGRV1	2.13e-05	179	83	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Somatosensory_Cortex_(S1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPP6 METTL21C CCDC168 ITGA4 IL1RAP	2.13e-05	179	83	5	82348bf56a4525b2f485696cab5b2ea6e96c2f91
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR TKT	2.13e-05	179	83	5	7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR ABCD3	2.31e-05	182	83	5	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDS1 PIGR NELFB MUC5B MUC2	2.49e-05	185	83	5	ef3c1fd52d21d96f81fb0e5097b24be0ce16e222
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDS1 PIGR NELFB MUC5B MUC2	2.49e-05	185	83	5	c357fa098b561da16c9fa82b0c3563b5cd3fa875
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDS1 METTL21C SMARCA2 CCDC168 IL1RAP	2.49e-05	185	83	5	5a0340c25196453f19e424d346efbf66d2c53ac3
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP6 NRXN3 EML5 DRAM1 ABCD3	2.56e-05	186	83	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	SMG-Goblet\|World / shred by cell class for bronchial biopsy	DPY19L3 PIGR ACLY GMDS MUC5B	2.62e-05	187	83	5	5178118bdec91495253c88f58fd908cf831de7ef
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DPP4 ELAPOR2 DRAM1 MYO6 ADGRV1	2.62e-05	187	83	5	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP6 CDS1 NRXN3 DRAM1 ABCD3	2.69e-05	188	83	5	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	DPP4 ELAPOR2 DRAM1 PIGR ADGRV1	2.76e-05	189	83	5	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDS1 DYNC2LI1 EML6 GMDS DNAH14	2.76e-05	189	83	5	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ELAPOR2 CDS1 MYO6 ADGRV1 DNAH14	2.98e-05	192	83	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 ELAPOR2 CDS1 DRAM1 ABCD3	3.05e-05	193	83	5	1fdfe08b0c82248545c29b504ac259b093fde29b
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 ELAPOR2 CDS1 DRAM1 ABCD3	3.05e-05	193	83	5	5f90e3e526032d82d9dc7e0813fe79ca28dc0719
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ELAPOR2 CDS1 NRXN3 EML5 PIGR	3.37e-05	197	83	5	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DPP4 NRXN3 DRAM1 PIGR MUC5B	3.37e-05	197	83	5	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	5'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP4 CRYL1 PIGR SLC5A9 LCT	3.45e-05	198	83	5	8d629492d2199de8e036c19e9dacceb9c9e721a0
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ELAPOR2 CDS1 NRXN3 PIGR ABCD3	3.45e-05	198	83	5	aa80315395cb5dffc25927c8a77cd2037aea8772
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ELAPOR2 DRAM1 MYO6 ADGRV1 DNAH14	3.53e-05	199	83	5	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ELAPOR2 DRAM1 MYO6 ADGRV1 DNAH14	3.53e-05	199	83	5	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP4 CRYL1 PIGR SLC5A9 LCT	3.53e-05	199	83	5	01c2721bc82cd672e9477029b4a7ecc77e2f1b00
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CRYL1 GLUL ADA PREX1 MYORG	3.62e-05	200	83	5	29f82e2ad2f1888b6b236a4392b88a84351b8ddc
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PIGR MYO6 GMDS MUC5B ADGRV1	3.62e-05	200	83	5	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CDS1 MYO6 GLUL ADGRV1 LGI1	3.62e-05	200	83	5	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CRYL1 GLUL ADA PREX1 MYORG	3.62e-05	200	83	5	1598a9e8efa72fda7d12df07e7716b326cdf1d5e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CDS1 MYO6 GLUL ADGRV1 LGI1	3.62e-05	200	83	5	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	droplet-Heart-HEART-1m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYL1 IFT140 ABCD1 ITGA4	9.36e-05	127	83	4	983489a69d3b1f1fe21110a862ac1dba53e9d31c
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7\|TCGA-Stomach / Sample_Type by Project: Shred V9	DPP6 NRXN3 GRIA1 LGI1	9.36e-05	127	83	4	5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	TRMT1L RFESD IL1RAP MUC2	1.40e-04	141	83	4	330f944b38c3170dfc79ab033fae7b9ab71e840d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM53 MYO6 EML6 MYL10	1.87e-04	152	83	4	acfafdb64bd5b0eb7371b04cfef51ed2798e9b30
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM53 MYO6 EML6 MYL10	1.87e-04	152	83	4	9d6c88ceca0569dbeb12e488acec7fcb7f972f03
ToppCell	severe_influenza-NK_CD56bright\|World / disease group, cell group and cell class (v2)	MATK CCDC168 RFESD CABIN1	1.97e-04	154	83	4	187b9d4eb0e98c506034735601ead480ff00bd57
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DPP4 CDS1 DRAM1 MATN3	2.02e-04	155	83	4	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	COVID-19-Myeloid-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	PROKR2 GLUL ITGA4 PREX1	2.07e-04	156	83	4	a07a9096799e4ba663841c70035b4b32c1fda4f9
ToppCell	Goblet\|World / Class top	PIGR GMDS MUC5B PMM2	2.12e-04	157	83	4	b352aa37d662629db6a9c6def9ee6d7c49a9071c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 RHOXF1 CCDC168 LCT	2.22e-04	159	83	4	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 RHOXF1 CCDC168 LCT	2.22e-04	159	83	4	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP6 RHOXF1 CCDC168 LCT	2.22e-04	159	83	4	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 PIGR MYO6 TKT	2.50e-04	164	83	4	beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell	5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PIGR GMDS ADGRV1 MUC2	2.50e-04	164	83	4	29da0175bd3808a5b3039a6161c764105608ef96
ToppCell	5'-Adult-Appendix-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PIGR GMDS ADGRV1 MUC2	2.50e-04	164	83	4	e83b632ac7e1dace946991ddfe1fbfbbffc3a88b
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 PIGR MYO6 TKT	2.50e-04	164	83	4	d005cfd821b87548b075120bffe65a0be9860463
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAB24 ACLY GLUL IL1R1	2.62e-04	166	83	4	66026988509e39e41274fa0de738383219e8ff30
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIGR MUC5B ACOX2 PMM2	2.68e-04	167	83	4	8fede587572d465cb63f7828141a574185bbb819
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN3 PIGR GMDS MUC5B	2.80e-04	169	83	4	db73dae011ff3749b3706e50ab46d03b775dd6bb
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN3 PIGR GMDS MUC5B	2.80e-04	169	83	4	97b7047b87ce0052d8580565c9b44fd2aa6f0d5c
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN3 PIGR GMDS MUC5B	2.80e-04	169	83	4	1a684471dbda42e1470e5a889648666e14f25982
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC18A3 MATK ETNK2 NDST4	2.87e-04	170	83	4	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN3 PIGR ARNT2 MUC5B	2.93e-04	171	83	4	eddc5e05003382603ee49f74b9e2242a43021096
ToppCell	facs-GAT-Fat-24m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIGR SLC5A9 GMDS ADGRV1	3.06e-04	173	83	4	815ba48a9222ea09ba8005e2d2f7c5addf118ad1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	METTL21C CCDC168 IL1RAP DNAH14	3.06e-04	173	83	4	8335b77f730ed43fc348a005566e73a103c6774b
ToppCell	facs-GAT-Fat-24m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIGR SLC5A9 GMDS ADGRV1	3.06e-04	173	83	4	98e464d9e6d6b69421e9e4041b638b6825247f60
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA4 SLC5A9 ITGA4 MYL10	3.06e-04	173	83	4	5d7c53c6d1cdd385e44b79b82faec901747d1736
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPY19L3 METTL21C CCDC168 IL1RAP	3.06e-04	173	83	4	8ac2e9d39c0f76e674f8bd59d1da246bab4867c8
ToppCell	facs-GAT-Fat-24m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIGR SLC5A9 GMDS ADGRV1	3.06e-04	173	83	4	3e6f0a08eddfd61871f7a85acccf6d539af6ebda
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 SMARCA4 SLC5A9 MYL10	3.13e-04	174	83	4	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	METTL21C CCDC168 IL1RAP DNAH14	3.13e-04	174	83	4	b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 DPP6 NRXN3 DRAM1	3.13e-04	174	83	4	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYL1 PIGR IL1RAP ACOX2	3.20e-04	175	83	4	5c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell	10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ESYT1 GLUL DEPDC5 PREX1	3.27e-04	176	83	4	581d78811b2d99f38a2c7cc268aeb1cf932379c2
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 SMARCA4 SLC5A9 MYL10	3.27e-04	176	83	4	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRXN3 PIGR ARNT2 MUC5B	3.34e-04	177	83	4	a235ff4f37a7622216526191efc4832fb8ed6957
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRXN3 PIGR MUC5B ADGRV1	3.34e-04	177	83	4	a4c001a8e44142babf9f24dfe6f7b73a70b11b16
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRXN3 PIGR MUC5B ADGRV1	3.34e-04	177	83	4	363e07b0f347f3716d530a28ead854b98e27d37c
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PIGR MYO6 RHOXF1 MUC5B	3.41e-04	178	83	4	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	lung\|World / shred on tissue and cell subclass	ELAPOR2 DRAM1 GLUL IL1R1	3.41e-04	178	83	4	7b1e371272328d6b6c3994382d64281ffc737db2
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIGR MYO6 RHOXF1 MUC5B	3.41e-04	178	83	4	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PIGR MYO6 RHOXF1 MUC5B	3.41e-04	178	83	4	49a2271718637522f74334068d252963ee13b1ce
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PIGR MYO6 RHOXF1 MUC5B	3.41e-04	178	83	4	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ELAPOR2 CDS1 DRAM1 ABCD3	3.48e-04	179	83	4	bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NRXN3 MATN3 SMARCA2 GRIA1	3.48e-04	179	83	4	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR	3.56e-04	180	83	4	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	HSPCs-Erythroblasts\|World / Lineage and Cell class	IFT140 CHST10 KLHL12 RFESD	3.63e-04	181	83	4	ce26f1accc8f69b7bc4b929073e975c887566c6a
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IFT140 RAB24 ITGA4 TECPR1	3.71e-04	182	83	4	69b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee
ToppCell	severe-Myeloid-Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	GLUL IL1R1 IL1RAP PREX1	3.79e-04	183	83	4	60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP4 NRXN3 SLC5A9 GMDS	3.79e-04	183	83	4	6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	GLUL IL1R1 IL1RAP PREX1	3.79e-04	183	83	4	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 PIGR	3.79e-04	183	83	4	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 DRAM1 PIGR ADGRV1	3.87e-04	184	83	4	0ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	DPP4 PIGR MYO6 ADGRV1	3.87e-04	184	83	4	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 CDS1 NRXN3 ADGRV1	3.87e-04	184	83	4	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDS1 DYNC2LI1 EML6 GMDS	3.87e-04	184	83	4	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDS1 NRXN3 DRAM1 ABCD3	3.87e-04	184	83	4	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ELAPOR2 DRAM1 PIGR ADGRV1	3.87e-04	184	83	4	2a8338e94937686a148b5433515700ca0f674058
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 DRAM1 ACLY ABCD3	3.95e-04	185	83	4	fd51fef8c69e34c72017d8371ab0a0d7be5701f2
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 DRAM1 ACLY ABCD3	3.95e-04	185	83	4	bea26e369ae91006052b973cd89b4c49afa9e553
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ELAPOR2 CDS1 NRXN3 ADGRV1	3.95e-04	185	83	4	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM53 DRAM1 IL1RAP ADA	3.95e-04	185	83	4	53854a9ec87c24c360541c83d86d8fafb303ad58
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPY19L3 PIGR GMDS MUC5B	3.95e-04	185	83	4	d9039770226338fbc3fce92aa229fad96e16db8c
Drug	ferrous oxalate dihydrate	CDS1 GMDS LGI1	3.86e-06	9	83	3	CID000516788
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A	MYO1C DRAM1 SMARCA4 TNKS2 MYL10 IL1RAP EFR3A	7.27e-06	195	83	7	2017_DN
Disease	Polydactyly	ARL6 IFT140 TRIM32 DYNC2LI1 IFT172 KIF7	7.50e-07	117	79	6	C0152427
Disease	Jeune thoracic dystrophy	IFT140 DYNC2LI1 IFT172	3.00e-06	11	79	3	C0265275
Disease	opioid dependence	DPP4 CRYL1 NRXN3 MYO6 SMARCA2 ADGRV1 IL1RAP	3.50e-06	237	79	7	EFO_0005611
Disease	Short Rib-Polydactyly Syndrome	IFT140 DYNC2LI1 IFT172	5.18e-06	13	79	3	C0036996
Disease	Saldino-Noonan Syndrome	IFT140 DYNC2LI1 IFT172	6.58e-06	14	79	3	C0036069
Disease	Majewski Syndrome	IFT140 DYNC2LI1 IFT172	6.58e-06	14	79	3	C0024507
Disease	Mainzer-Saldino Disease	IFT140 IFT172	7.08e-06	2	79	2	C1849437
Disease	Bardet-Biedl syndrome 1 (disorder)	ARL6 TRIM32 KIF7	1.22e-05	17	79	3	C2936862
Disease	Autosomal Dominant Lateral Temporal Lobe Epilepsy	DEPDC5 LGI1	2.12e-05	3	79	2	C1838062
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	7.04e-05	5	79	2	C3281201
Disease	adrenoleukodystrophy (implicated_via_orthology)	ABCD3 ABCD1	1.47e-04	7	79	2	DOID:10588 (implicated_via_orthology)
Disease	Septo-Optic Dysplasia	PROKR2 ARNT2	1.47e-04	7	79	2	C0338503
Disease	Retinitis Pigmentosa	ARL6 IFT140 PDE6A IFT172	1.79e-04	104	79	4	C0035334
Disease	Intellectual Disability	AP2M1 MTOR KAT8 GRIA1 DYNC1H1 KIF7 PMM2	1.98e-04	447	79	7	C3714756
Disease	Ciliopathies	ARL6 TRIM32 ADGRV1 KIF7	2.22e-04	110	79	4	C4277690
Disease	temporal lobe epilepsy (implicated_via_orthology)	MTOR GLUL	2.52e-04	9	79	2	DOID:3328 (implicated_via_orthology)
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	2.52e-04	9	79	2	DOID:0050340 (implicated_via_orthology)
Disease	Carcinoma, Small Cell	MTOR SMARCA4	2.52e-04	9	79	2	C0262584
Disease	Disorder of eye	ARL6 PDE6A TRIM32 ADGRV1 KIF7	2.67e-04	212	79	5	C0015397
Disease	pneumonia (implicated_via_orthology)	ITGA4 MUC2	3.14e-04	10	79	2	DOID:552 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	5.42e-04	13	79	2	C0265338
Disease	Bardet-Biedl Syndrome	ARL6 IFT172	5.42e-04	13	79	2	C0752166
Disease	Malformations of Cortical Development	MTOR DYNC1H1	6.31e-04	14	79	2	C1955869
Disease	Bardet-Biedl syndrome (is_implicated_in)	ARL6 TRIM32	6.31e-04	14	79	2	DOID:1935 (is_implicated_in)
Disease	Cortical Dysplasia	MTOR DYNC1H1	6.31e-04	14	79	2	C0431380
Disease	susceptibility to hepatitis B infection measurement	EML6 GMDS PREX1	6.84e-04	64	79	3	EFO_0008405
Disease	Autistic Disorder	NRXN3 KAT8 GRIA1 ITGA4 ADA	6.89e-04	261	79	5	C0004352
Disease	cancer (implicated_via_orthology)	CDS1 MTOR SMARCA2 SMARCA4 DEPDC5	7.76e-04	268	79	5	DOID:162 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	MYO6 SMARCA2 SMARCA4 PREX1	8.30e-04	156	79	4	DOID:10283 (is_marker_for)
Disease	immature granulocyte count	DEPDC5 ITGA4	9.38e-04	17	79	2	EFO_0803542
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	AP2M1 GRIA1	9.38e-04	17	79	2	DOID:0060307 (is_implicated_in)
Disease	epilepsy (implicated_via_orthology)	ETNK2 DEPDC5 DYNC1H1 LGI1	9.77e-04	163	79	4	DOID:1826 (implicated_via_orthology)
Disease	Bardet-Biedl syndrome	ARL6 TRIM32	1.05e-03	18	79	2	cv:C0752166
Disease	disease free survival	METTL21C CCDC168	1.05e-03	18	79	2	EFO_0000409
Disease	blood aluminium measurement	DPP6 EFR3A	1.30e-03	20	79	2	EFO_0007575
Disease	Arthrogryposis	SLC18A3 DYNC1H1	1.44e-03	21	79	2	C0003886
Disease	cerebral amyloid deposition measurement	CDS1 NRXN3 EFR3A	2.14e-03	95	79	3	EFO_0007707
Disease	Kallmann Syndrome	PROKR2 ARNT2	2.21e-03	26	79	2	C0162809
Disease	Liver carcinoma	MTOR ACLY TMEM70 GLUL DEPDC5 IL1RAP	2.41e-03	507	79	6	C2239176

Protein segments in the cluster

Peptide	Gene	Start	Entry
YYSEERKLVSIVHGC	ESYT1	981	Q9BSJ8
HCYYVTVKGFTEALE	ACOX2	546	Q99424
AKEGVVYVEVRYSPH	ADA	91	P00813
KCFHEIITIGYRVYH	CDS1	121	Q92903
VERTRGALDYVHVFY	ADGRV1	1596	Q8WXG9
SEVYVVCLHYKGREA	CMTR2	311	Q8IYT2
EHYYKEGQAIIFVID	ARL6	81	Q9H0F7
VYQIYAKRAPEEVHA	DPY19L3	611	Q6ZPD9
YRHIYLGCKEEDNVQ	EFR3A	531	Q14156
KEGEAQYAVVHCTGY	ARNT2	271	Q9HBZ2
EVIYNKTDRAGCHFY	MUC5B	4956	Q9HC84
EYVGKTSLVERYVHD	RAB24	16	Q969Q5
HVKNDYLIGDVYVER	LTN1	781	O94822
YKEVTELAGYTARVH	ABCD1	406	P33897
REKDYVYHVVSAICE	DRAM1	191	Q8N682
HKGRFYEDFYKVVVQ	DEPDC5	246	O75140
HVFYVETYGVIEKLS	MATN3	241	O15232
YVLCVSFGRDVIHYR	MATK	156	P42679
ETGKVHVTVDLKYYR	GMDS	311	O60547
EVKVNGEYIYAFVHR	LGALS16	101	A8MUM7
VHKLYIEYGIQRITC	IL1RAP	146	Q9NPH3
ISVYEVDGKDHKIYC	KAT8	246	Q9H7Z6
VICKTLRFVAHYYGA	DYNC2LI1	201	Q8TCX1
IYDSIKGHVRFIDYE	ETNK2	256	Q9NVF9
VDYKNICYVITHGDA	MYLPF	151	Q96A32
HVAYTTREVGQYLVV	MUC2	946	Q02817
REINFYKVIDYILHG	PDE6A	311	P16499
NDFIAVELVKGYIHY	NRXN3	916	Q9Y4C0
VHVSYLEVYKEEFRD	KIF7	141	Q2M1P5
ACEVGLYYVLHITKQ	NELFB	421	Q8WX92
AVIKAHARVYHTYDE	LCT	1096	P09848
FYKIISNEEGYRHIC	DPP4	371	P27487
DYRNLCYVITHGEEK	MYL10	211	Q9BUA6
FIYNHKGEVLISRVY	AP2M1	6	Q96CW1
EKYCVEYSVSIIGFH	NDST4	151	Q9H3R1
VHDREVVIFYHKGEY	RFESD	36	Q8TAC1
TYLSIHQVYGKEACI	ELAPOR2	641	A8MWY0
EIVYSGKHNGICIYF	NUP155	656	O75694
RVVLKSHYGYEVEEV	IFT172	346	Q9UG01
YTQEHYRFAGKEIVI	METTL21C	66	Q5VZV1
YVASVSLHDRIYVIG	KLHL12	321	Q53G59
IQRLYEAGDYKAVVH	CABIN1	696	Q9Y6J0
IFYGHCVDKYHVKVL	DNAH14	3006	Q0VDD8
VVQLDCSIGYIYVDH	ITGA4	706	P13612
VGVHYELTEEEKFYR	DYNC1H1	1006	Q14204
YCDRYSEGIKHVLQT	CRYL1	251	Q9Y2S2
EIVYHVAAVGVIYNR	EML5	701	Q05BV3
EVVYHIAAVAVVYNR	EML6	701	Q6ZMW3
HRVLKAVYDSGYCVS	CCDC168	2846	Q8NDH2
NIYYCAHVGKQAIRV	DPP6	261	P42658
IAKHVGYSYRLEIVS	GRIA1	446	P42261
FLVEHYVRKEEYQTA	IFT140	1381	Q96RY7
AKVEDSGHYYCVVRN	IL1R1	86	P14778
HQRYDVLICRIVKGY	MTOR	1206	P42345
YCLRHVENDGYKTIY	PMM2	191	O15305
VEAHYRACLYAGVKI	GLUL	176	P15104
VHDTVFYCLSVYQVK	RHOXF1	6	Q8NHV9
HYGCNIVRTEYYKEL	TRMT1L	416	Q7Z2T5
YKAVLQEYGHEERRV	TRIM32	181	Q13049
VRHVSVYGSVYAIAD	SLC18A3	411	Q16572
YYTVAHAISERVEKQ	SMARCA2	701	P51531
DYIYHGTVKLRAEEL	KBTBD4	101	Q9NVX7
VYEYVSTAGVRCHVL	PREX1	856	Q8TCU6
YYAVAHAVTERVDKQ	SMARCA4	731	P51532
RVKRYIVEHVDLGAY	SIPA1L1	476	O43166
VGLHAYDISVVVIYF	SLC5A9	31	Q2M3M2
VSVDVEGYIYSHCRK	ABCD3	601	P28288
VCIYATREGDYVLFH	ACLY	121	P53396
GITVYNRTKVEHYFL	CHST10	311	O43529
RASVKEQDYLCHVYV	YKT6	56	O15498
TYHYVPEFRKVSIAA	YIPF1	151	Q9Y548
ATKGRILTVEDHYYE	TKT	551	P29401
GVRDSILFIYYVVHE	TECPR1	641	Q7Z6L1
AIYHKRGCIVIRYTA	TMEM53	56	Q6P2H8
VKEKHYLTAFYVVEC	PROKR2	306	Q8NFJ6
VKQGHFYGETAAVYV	PIGR	546	P01833
ACSYGHYEVTELLVK	TNKS2	251	Q9H2K2
YDYLKTLAGDVHIVR	VPS29	46	Q9UBQ0
FITKGYVIRLYHEAT	TMEM70	161	Q9BUB7
DVYAVKHFSVKGDVY	LGI1	431	O95970
EFRLLHYAGEVTYSV	MYO1C	541	O00159
CVQGKEERNYHIFYR	MYO6	236	Q9UM54
YRVCVGSDVTSIHKY	MYORG	281	Q6NSJ0
YESVLCVKPDVHVYR	NECAP2	6	Q9NVZ3